Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1404364-72-2

Post Buying Request

1404364-72-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1404364-72-2 Usage

General Description

7-((2-(trimethylsilyl)ethoxy)methyl)-2,4-dichloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine is a complex chemical compound with a long and specific name. It is a derivative of pyrrolopyrimidine and contains two chlorine atoms, one iodine atom, and a trimethylsilyl group. 7-((2-(triMethylsilyl)ethoxy)Methyl)-2,4-dichloro-5-iodo-7H-pyrrolo[2,3-d]pyriMidine is often used in research and development as a building block for the synthesis of various pharmaceuticals and agrochemicals. Its specific properties and applications may vary depending on the context in which it is used, but it is generally known for its potential as a key intermediate in the production of biologically active compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 1404364-72-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,4,3,6 and 4 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1404364-72:
(9*1)+(8*4)+(7*0)+(6*4)+(5*3)+(4*6)+(3*4)+(2*7)+(1*2)=132
132 % 10 = 2
So 1404364-72-2 is a valid CAS Registry Number.

1404364-72-2Downstream Products

1404364-72-2Relevant articles and documents

Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk)

Tang, Guanghui,Liu, Lihong,Wang, Xueying,Pan, Zhengying

, p. 167 - 183 (2019)

Interleukin-2-inducible T-cell kinase (Itk) plays an important role in multiple signal transduction pathways in T and mast cells, and is a potential drug target for treating inflammatory diseases, autoimmune diseases, and T cell leukemia/lymphoma. Herein,

Enhancement of anti-tumor activity of SHP2 inhibitor pyrimidinone in combination with novel cancer medicines in cancers

-

Paragraph 0135, (2021/07/31)

The present invention provides a combination drug for the treatment of a malignant tumor comprising 2-((1R,2R,4S)-2-amino-7-azabicyclo[2.2.1]heptan-7-yl)-5-(3,4-dichloro-2-methyl-2H-indazol-5-yl)-3-methyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one or a

HETEROBICYCLIC COMPOUNDS FOR INHIBITING THE ACTIVITY OF SHP2

-

Paragraph 0318-0320, (2020/02/16)

A compound of formula (I):wherein Ring A, Q, R1,R2, R3, R4, R5, R6, R7, R8, R9, R10, R11,X, a,b, c and d are as defined in the specification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1404364-72-2